Has John Iskikian, MD received payments from drug or device companies?

Yes. Drug and device makers reported $760 in general payments to John Iskikian, MD across 8 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Iskikian, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Iskikian, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Iskikian, MD

Cardiovascular Disease · Yuba City, CANPI 1962478347

Payments from drug & device makers

$760in general payments, 2019–2025

Across 8 payments — averaging $94.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$524
Boston Scientific$145
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$66
Amgen$25

What the payments were for

Grants$14519%
Food & beverage$61581%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	4	$524
Boston Scientific	1	$145
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$66
Amgen	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$760 in reported general payments places this provider in the 30th percentile of 2,184 cardiovascular disease providers in California.

See all cardiovascular disease providers in California →

Medicare billing

Part B allowed, 2024

$223,658

Medicare patients

559

Services billed

3,798

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	50	$65,469
EntrestoSacubitril/Valsartan	17	$11,984
XareltoRivaroxaban	13	$11,423
FarxigaDapagliflozin Propanediol	12	$6,609
Metoprolol Succinate	52	$1,001
Amiodarone Hcl	14	$731
Valsartan	14	$586
Amlodipine Besylate	66	$574
Digoxin	25	$474
ClopidogrelClopidogrel Bisulfate	37	$435
Atorvastatin Calcium	48	$423
Ezetimibe	23	$371
Losartan Potassium	36	$284
Metoprolol Tartrate	37	$200
Nitroglycerin	16	$181

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Yuba City

Ted LoveHillsborough$102.8M
Matthew BudoffTorrance$11.3M
Lori DanielsSan Diego$10.2M
Paul KurthSanta Barbara$6.1M
Michael BlumSan Francisco$5.5M
Tony ChouSan Francisco$5.2M
Jason RogersSacramento$5.1M
Yu-Ping WangStanford$3.8M
Yogesh PaliwalPomona$3.3M
Farhad RafiiWest Hills$3.2M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →